XTL Biopharmaceuticals Ltd (XTLB)
2.53
0.00 (0.00%)
USD |
NASDAQ |
May 03, 16:00
2.53
0.00 (0.00%)
After-Hours: 20:00
XTL Biopharmaceuticals Enterprise Value: 11.58M for May 3, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| May 03, 2024 | 11.58M |
| May 02, 2024 | 11.55M |
| May 01, 2024 | 11.96M |
| April 30, 2024 | 11.91M |
| April 29, 2024 | 10.98M |
| April 26, 2024 | 10.99M |
| April 25, 2024 | 10.87M |
| April 24, 2024 | 11.74M |
| April 23, 2024 | 11.91M |
| April 22, 2024 | 12.23M |
| April 19, 2024 | 11.09M |
| April 18, 2024 | 11.09M |
| April 17, 2024 | 11.25M |
| April 16, 2024 | 11.96M |
| April 15, 2024 | 12.40M |
| April 12, 2024 | 11.96M |
| April 11, 2024 | 12.83M |
| April 10, 2024 | 12.94M |
| April 09, 2024 | 15.12M |
| April 08, 2024 | 14.96M |
| April 05, 2024 | 15.56M |
| April 04, 2024 | 14.74M |
| April 03, 2024 | 15.94M |
| April 02, 2024 | 13.16M |
| April 01, 2024 | 14.20M |
| Date | Value |
|---|---|
| March 28, 2024 | 13.11M |
| March 27, 2024 | 12.51M |
| March 26, 2024 | 14.52M |
| March 25, 2024 | 13.11M |
| March 22, 2024 | 12.07M |
| March 21, 2024 | 10.98M |
| March 20, 2024 | 10.76M |
| March 19, 2024 | 3.461M |
| March 18, 2024 | 4.109M |
| March 15, 2024 | 2.589M |
| March 14, 2024 | 2.611M |
| March 13, 2024 | 2.971M |
| March 12, 2024 | 3.025M |
| March 11, 2024 | 3.025M |
| March 08, 2024 | 2.807M |
| March 07, 2024 | 2.426M |
| March 06, 2024 | 2.75M |
| March 05, 2024 | 2.752M |
| March 04, 2024 | 2.698M |
| March 01, 2024 | 2.698M |
| February 29, 2024 | 2.559M |
| February 28, 2024 | 2.174M |
| February 27, 2024 | 2.478M |
| February 26, 2024 | 2.478M |
| February 23, 2024 | 2.400M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
-2.100M
Minimum
Mar 27 2020
21.17M
Maximum
Sep 02 2021
6.280M
Average
4.197M
Median
May 16 2023
Enterprise Value Benchmarks
| Compugen Ltd | 138.22M |
| Pluri Inc | 26.05M |
| BioLine Rx Ltd | 21.14M |
| Can Fite Biofarma Ltd | 1.508M |
| BiomX Inc | 17.48M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -0.215M |
| Total Expenses (Quarterly) | 0.151M |
| EPS Diluted (Quarterly) | -0.0645 |
| Earnings Yield | -15.81% |
| Normalized Earnings Yield | -19.87 |